Brain

brain.space ANNOUNCES $11M SERIES A FUNDING ROUND TO ACCELERATE DESIGN OF BRAIN DATA-DRIVEN MENTAL MODELING

Neurotechnology Pioneer Utilizes Standardized Brain Data to Predict Human Behavior, Enhance Digital Systems across Consumer, Health, Defense, and Aerospace TEL…

11 months ago

Mindbody Partners with Rokt to Deliver Highly Relevant Online Ad Experiences to Its Fitness and Wellness Members

NEW YORK, March 18, 2025 /PRNewswire/ -- Mindbody, the leading experience technology platform for the wellness industry, today announced it…

11 months ago

Madison Scientific Closes $7M in Seed Financing

Funds will be used to advance development of the company's SmartShunt™ System that aims to address current challenges with existing hydrocephalus…

11 months ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace

EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a…

11 months ago

March 2025 Letter to Shareholders

VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year…

11 months ago

Octane’s First ‘Neuro Tech Forum’: Cutting-Edge Innovations and Global Leaders Converge in Newport Beach, April 2025

Southern California's Leading Medtech Octane's Premier Event Unites Global Stakeholders and Spotlights Innovations in Neuroscience and Technology for a Day…

11 months ago

VAS101, a Novel Curcumin Transdermal Formulation, Reverses Some Clinical Hallmarks of Aging

SUMMIT, N.J., March 17, 2025 /PRNewswire/ -- In a new study published in the journal GeroScience, VAS101 (Vasceptor®), a novel…

11 months ago

Baird Medical’s AI Tumor Ablation Surgical Robot Wins “Most Valuable Investment Award,” Pioneering AI and Robotics Integration in Healthcare

NEW YORK, March 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been…

11 months ago

Hemostemix’s Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial

Calgary, Alberta--(Newsfile Corp. - March 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an…

11 months ago

Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation

Collaboration aims to make portable MRI faster, smarter, and more accessible worldwide. GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking…

11 months ago